Replimune Group REPL Weighted Average Exercise Price of Exercisable Options

Weighted Average Exercise Price of Exercisable Options at other companies

BillionToOne, Inc. BLLN

$7.04—

NuScale PowerSMR

$3.86-1.0%

Community Financial SystemCBU

$57.10+3.9%

Ondas, Inc. ONDS

$3.51-23.7%

HTF

Heartflow, Inc. Common StockHTFL

5.6—

TFS FinancialTFSL

$15.81+2.7%

Other financials

Income statement

See full

Operating income-$71.9M-8.9%

Net income-$70.9M-6.9%

EPS (diluted)-$0.77+2.5%

Balance sheet

See full

Cash & equivalents$124.7M-28.3%

Total debt$79.2M+0.5%

Total equity$210.5M-56.4%

Total assets$333.6M-44.7%

Cash flow

See full

Operating cash flow-$66.0M-30.1%

CapEx$135.0K-92.5%

Free cash flow-$66.1M-25.9%

Valuation

See full

Market cap$930.59M+28.6%

Enterprise value$885.15M+28.3%

Returns & leverage

See full

Return on equity-90.9%+362pp

Debt / equity0.4×+0.2×

Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's weighted average exercise price of exercisable options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Replimune Group's weighted average exercise price of exercisable options?: Replimune Group (REPL) reported weighted average exercise price of exercisable options of $14.10 in Q4 2025.
How has Replimune Group's weighted average exercise price of exercisable options changed year-over-year?: Replimune Group's weighted average exercise price of exercisable options decreased by 7.7% year-over-year, from $15.28 to $14.10.